Ucb Biosciences, Inc.
Clinical trials sponsored by Ucb Biosciences, Inc., explained in plain language.
-
New hope for babies with severe epilepsy: drug trial targets seizures in toddlers
Disease control OngoingThis study tests a medicine called fenfluramine in 25 infants aged 1 to 2 years who have Dravet syndrome, a severe form of epilepsy. The goal is to see if the drug is safe and can reduce seizures. Researchers will closely monitor heart health and growth, since the medicine has kn…
Phase: PHASE3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated May 17, 2026 17:18 UTC
-
New hope for rare genetic disease: oral drug combo under study
Disease control OngoingThis study tests the safety and effectiveness of two oral drugs (doxecitine and doxribtimine) in people with thymidine kinase 2 (TK2) deficiency, a rare genetic condition that causes muscle weakness and breathing problems. About 47 participants who are already receiving similar t…
Phase: PHASE2 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated May 04, 2026 16:18 UTC